A kinetic differentiation model for the action of altered TCR ligands. (Q33542325)

27 July 2017

title

A kinetic differentiation model for the action of altered TCR ligands. (English)

1 reference

ORCID Public Data File 2021

27 July 2017

1 reference

author name string

Lord GM

series ordinal

1

1 reference

27 July 2017

Lechler RI

series ordinal

2

1 reference

27 July 2017

George AJ

series ordinal

3

1 reference

27 July 2017

publication date

1 January 1999

1 reference

27 July 2017

language of work or name

1 reference

1 reference

27 July 2017

volume

20

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

33-39

1 reference

publication type of scholarly work

27 July 2017

review article

1 reference

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

T cell receptor antagonists and partial agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Partial signaling by CD8+ T cells in response to antagonist ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Dissociation of Intracellular Signaling Pathways in Response to Partial Agonist Ligands of the T Cell Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Specificity and flexibility in thymic selection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Fidelity of T Cell Activation Through Multistep T Cell Receptor ζ Phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Low Affinity Interaction of Peptide-MHC Complexes with T Cell Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

T-cell-receptor affinity and thymocyte positive selection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Serial engagement proposed

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Serial triggering of many T-cell receptors by a few peptide-MHC complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

T cell activation determined by T cell receptor number and tunable thresholds.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Significance of T-cell stimulation by altered peptide ligands in T cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Kinetic discrimination in T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Kinetic proofreading in T-cell receptor signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

T cell antigen receptor signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

High determinant density may explain the phenomenon of alloreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901379-6

7 January 2021

10.1016/S0167-5699(98)01379-6

Identifiers

DOI

1 reference

27 July 2017

1 reference